The RPCI Biopolymer Resource is a biomolecular core Resource that provides advice and technical services to the staff in the design, synthesis, and characterization of oligonucleotides and peptides; automated DNA sequencing; and the isolation, purification and characterization of proteins. The Resource emphasizes support to staff in developing and understanding the uses and applications of the various techniques and provides convenient access to the technical services. In order to accommodate the evolving research needs and interests of RPCI staff and to support the technical r requirements of the various projects, the Resource has recently added new areas of emphasis and expertise. These include fluorescence-based, """"""""real time"""""""" PCR for quantifying gene expression; mass spectrometry for the characterization (and identification) of proteins and peptides and generical applicability to proteomics; and the synthesis of """"""""specialty"""""""" oligonucleotides such as the dual-labeled probes. for fluorogenic N5'-nuclease assays. The DNA sequencing capability of the Resource has also been recently upgraded to higher sensitivity and throughput, and is now capable of sequencing BAC and PAC clones. The Resource continues to be a heavily used core resource-in 1998, technical services were provided to over 50 senior RPCI staff, supported over 80 publications, and there was an approximately 50% increased in the services provided in the areas of oligonucleotide synthesis, DNA sequencing, mas spectroscopy and chromatography. The new technical services offered by the Resource have increased and diversified its user base, and as these techniques become fully implemented, use of the Resource is expected to further increase.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-25
Application #
6324614
Study Section
Project Start
2000-06-28
Project End
2001-04-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Miller, James A; Harris, Kassem; Roche, Charles et al. (2018) Sarcopenia is a predictor of outcomes after lobectomy. J Thorac Dis 10:432-440
Fenstermaker, Robert A; Figel, Sheila A; Qiu, Jingxin et al. (2018) Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo. Clin Cancer Res 24:2642-2652
Bhat, Tariq A; Kalathil, Suresh Gopi; Bogner, Paul N et al. (2018) Secondhand Smoke Induces Inflammation and Impairs Immunity to Respiratory Infections. J Immunol 200:2927-2940
Merzianu, Mihai; Groman, Adrienne; Hutson, Alan et al. (2018) Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study. Am J Clin Pathol 150:393-405
Qin, Bo; Llanos, Adana A M; Lin, Yong et al. (2018) Validity of self-reported weight, height, and body mass index among African American breast cancer survivors. J Cancer Surviv 12:460-468
Qiao, Guanxi; Chen, Minhui; Bucsek, Mark J et al. (2018) Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response. Front Immunol 9:164
Muramatsu, Masashi; Akakura, Shin; Gao, Lingqiu et al. (2018) SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk. Oncotarget 9:33515-33527
Kumar, Sandeep; Inigo, Joseph R; Kumar, Rahul et al. (2018) Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Cancer Lett 413:82-93
Liu, Chunhong; Yu, Tao; Xing, Zhuo et al. (2018) Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors. Oncotarget 9:4773-4786
Cimato, Thomas R; Conway, Alexis; Nichols, Julianne et al. (2018) CD133 expression in circulating hematopoietic progenitor cells. Cytometry B Clin Cytom :

Showing the most recent 10 out of 1555 publications